Using HPV-meta for human papillomavirus RNA quality detection
- PMID: 35906372
- PMCID: PMC9338075
- DOI: 10.1038/s41598-022-17318-5
Using HPV-meta for human papillomavirus RNA quality detection
Abstract
In the era of cervical cancer elimination, accurate and validated pipelines to detect human papillomavirus are essential to elucidate and understand HPV association with human cancers. We aimed to provide an open-source pipeline, "HPV-meta", to detect HPV transcripts in RNA sequencing data, including several steps to warn operators for possible viral contamination. The "HPV-meta" pipeline automatically performs several steps, starting with quality trimming, human genome filtering, HPV detection (blastx), cut-off settlement (10 reads and 690 bp coverage to make an HPV call) and finishing with fasta sequence generation for HPV positive samples. Fasta sequences can then be aligned to assess sequence diversity among HPV positive samples. All RNA sequencing files (n = 10,908) present in the cancer genome atlas (TCGA) were analyzed. "HPV-meta" identified 25 different HPV types being present in 488/10,904 specimens. Validation of results showed 99.98% agreement (10,902/10,904). Multiple alignment from fasta files warned about high sequence identity between several HPV 18 and 38 positive samples, whose contamination had previously been reported. The "HPV-meta" pipeline is a robust and validated pipeline that detects HPV in RNA sequencing data. Obtaining the fasta files enables contamination investigation, a non very rare occurrence in next generation sequencing.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers.J Gen Virol. 2020 Mar;101(3):265-270. doi: 10.1099/jgv.0.001374. J Gen Virol. 2020. PMID: 31859615
-
Metatranscriptome analysis in human papillomavirus negative cervical cancers.Sci Rep. 2022 Sep 5;12(1):15062. doi: 10.1038/s41598-022-19008-8. Sci Rep. 2022. PMID: 36064569 Free PMC article.
-
RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues.Mod Pathol. 2020 Apr;33(4):748-757. doi: 10.1038/s41379-019-0369-7. Epub 2019 Sep 19. Mod Pathol. 2020. PMID: 31537894
-
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis.J Gynecol Oncol. 2022 Jan;33(1):e4. doi: 10.3802/jgo.2022.33.e4. Epub 2021 Oct 7. J Gynecol Oncol. 2022. PMID: 34783207 Free PMC article.
-
Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing.Dis Markers. 2018 Nov 14;2018:4826547. doi: 10.1155/2018/4826547. eCollection 2018. Dis Markers. 2018. PMID: 30538783 Free PMC article. Review.
Cited by
-
Virome capture sequencing for comprehensive HPV genotyping in cervical samples.Sci Prog. 2025 Apr-Jun;108(2):368504251334515. doi: 10.1177/00368504251334515. Epub 2025 Apr 15. Sci Prog. 2025. PMID: 40232222 Free PMC article.
-
The Swedish Cervical Screening Cohort.Sci Data. 2024 Jun 26;11(1):697. doi: 10.1038/s41597-024-03519-2. Sci Data. 2024. PMID: 38926412 Free PMC article.
-
Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy.Infect Agent Cancer. 2024 Nov 14;19(1):57. doi: 10.1186/s13027-024-00619-x. Infect Agent Cancer. 2024. PMID: 39543738 Free PMC article.
References
-
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic